This study reports that PBMC from MM and MGUS patients shares an impaired ability to transduce proliferative signals via CD38, suggesting that CD38 activation pathway defects are already present in the MGUS pathology and are not feature acquired by MM. This evidence concerns the gene CD38 and Miyoshi myopathy.